- Home
- Site Map
- Widgets
- Articles
- Hind Sebti, Waldencast Co-Founder, featured on the cover of Forbes
- Fourth Quarter 2022 Financial Results on March 15th
- Participation in the 25th Annual ICR Conference
- Waldencast Announces Participation in the Canaccord Genuity 43rd Annual Growth Conference
- Beauty and wellness SPAC Waldencast Acquisition files for a $250 million IPO
- Waldencast Acquisition Files for $250M IPO
- Waldencast Acquisition Corp. Announces up to $633 Million Raise Behind Pricing of Upsized $300 Million Initial Public Offering and an Additional Investment of up to $333 Million in Forward Purchase Agreements
- Beauty Is Different – So We’re Building Something Different
- To Our Fellow Dreamers and Makers: A Multi-Year, Multi-Brand Journey Begins
- Waldencast Acquisition Corp. Announces up to $678 Million Raise Behind Closing of Upsized $345 Million Initial Public Offering
- Waldencast Acquisition Corp. Announces the Separate Trading of Its Class A Ordinary Shares and Redeemable Warrants Commencing May 10, 2021
- Waldencast Announces $1.2 Billion Three-Way Business Combination with Obagi and Milk Makeup as a First Step in its Strategy to Create a Global Multi-Brand Beauty and Wellness Platform
- Waldencast Announces Participation at D.A. Davidson 5th Annual Consumer Growth Conference and Evercore ISI CPG Growth Day
- Waldencast Announces Participation in the Cowen 6th Annual Future of the Consumer Conference
- Waldencast Announces Entry into $225m Term Loan and Revolving Credit Facilities
- Waldencast Registration Statement Related to Business Combination with Obagi Skincare and Milk Makeup Declared Effective by SEC
- Waldencast Acquisition Corp. Shareholders Approve Business Combination with Obagi Skincare and Milk Makeup
- Obagi Skincare, Milk Makeup and Waldencast Announce Closing of Business Combination, Advancing its Mission to Create a Global Best-in-Class Multi-Brand Beauty and Wellness Platform
- Obagi Skincare, Milk Makeup and Waldencast Close Business Combination; Combined Company to Begin Trading on Nasdaq
- Waldencast Announces Participation in the 25th Annual ICR Conference
- Waldencast Announces Participation in Upcoming Consumer Conferences
- Waldencast PLC to Report Fourth Quarter 2022 Financial Results on March 15th
- Waldencast PLC Announces Binding Letter of Intent to Acquire 60% of its Southeast Asia Distributor
- Waldencast PLC Announces its Intent to Delay the Filing of its Annual Report and Announces the Consummation of its Previously Announced Acquisition in Southeast Asia
- Waldencast Announces Participation in the TD Cowen 7th Annual Future of the Consumer Conference
- Hind Sebti, Waldencast Co-Founder, recognized as one of the Vogue Business 100 Beauty Disruptors
- Waldencast PLC Announces Private Placement and Expands Leadership Team to Support Growth
- Waldencast plc Announces Fiscal Year 2022 Financial Results
- Hind Sebti, Waldencast Co-Founder & CGO, Selected as Judge for the 2024 Pure Beauty Global Awards
- Waldencast Names Manuel Manfredi as Chief Financial Officer
- Dr. Suzan Obagi Appointed as Chief Medical Director at Obagi Cosmeceuticals, a Subsidiary of Waldencast plc.
- Waldencast Announces Creative Council
- Waldencast Receives Positive Nasdaq Listing Determination
- Waldencast Reports First Half 2023 Results
- Waldencast Regains Compliance with Nasdaq Filing Requirements
- Waldencast Reports Fiscal Year 2023 Financial Results
- Waldencast Announces Participation in CreatorIQ Connect Europe
- Waldencast plc Announces First Quarter Fiscal 2024 Earnings Release Date, Conference Call and Webcast
- Waldencast Reports Q1 2024 Financial Results
- Waldencast Announces Participation in Upcoming Investor Conferences
- Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates
- Waldencast Announces Participation in the Canaccord Genuity 44th Annual Growth Conference
- Waldencast plc Provides Second Quarter and First Half Fiscal 2024 Earnings Conference Call and Webcast Information
- Waldencast Reports Q2 2024 Financial Results
- Obagi Medical Announces the Launch of ELASTIDERM® Lift Up & Sculpt Facial Moisturizer and ELASTIDERM® Advanced Filler Concentrate
- Waldencast plc Announces Board Appointments and Annual General Meeting
- Waldencast Reports Q3 2024 Financial Results
- Waldencast plc Announces Third Quarter Fiscal 2024 Results Conference Call and Webcast
- Milk Makeup to Launch at Ulta Beauty This Spring
- Waldencast Announces Participation in the 2025 IMCAS World Congress
- Strategy & Model
- Our Brands
- About
- Our Team
- Newsroom
- Hind Sebti, Waldencast Co-Founder, featured on the cover of Forbes
- Waldencast Announces Participation in the Canaccord Genuity 43rd Annual Growth Conference
- Participation in the 25th Annual ICR Conference
- Fourth Quarter 2022 Financial Results on March 15th
- Beauty and wellness SPAC Waldencast Acquisition files for a $250 million IPO
- Waldencast Acquisition Files for $250M IPO
- Waldencast Acquisition Corp. Announces up to $633 Million Raise Behind Pricing of Upsized $300 Million Initial Public Offering and an Additional Investment of up to $333 Million in Forward Purchase Agreements
- Beauty Is Different – So We’re Building Something Different
- To Our Fellow Dreamers and Makers: A Multi-Year, Multi-Brand Journey Begins
- Waldencast Acquisition Corp. Announces up to $678 Million Raise Behind Closing of Upsized $345 Million Initial Public Offering
- Waldencast Acquisition Corp. Announces the Separate Trading of Its Class A Ordinary Shares and Redeemable Warrants Commencing May 10, 2021
- Waldencast Announces $1.2 Billion Three-Way Business Combination with Obagi and Milk Makeup as a First Step in its Strategy to Create a Global Multi-Brand Beauty and Wellness Platform
- Waldencast Announces Participation at D.A. Davidson 5th Annual Consumer Growth Conference and Evercore ISI CPG Growth Day
- Waldencast Announces Participation in the Cowen 6th Annual Future of the Consumer Conference
- Waldencast Announces Entry into $225m Term Loan and Revolving Credit Facilities
- Waldencast Registration Statement Related to Business Combination with Obagi Skincare and Milk Makeup Declared Effective by SEC
- Waldencast Acquisition Corp. Shareholders Approve Business Combination with Obagi Skincare and Milk Makeup
- Obagi Skincare, Milk Makeup and Waldencast Announce Closing of Business Combination, Advancing its Mission to Create a Global Best-in-Class Multi-Brand Beauty and Wellness Platform
- Obagi Skincare, Milk Makeup and Waldencast Close Business Combination; Combined Company to Begin Trading on Nasdaq
- Waldencast Announces Participation in the 25th Annual ICR Conference
- Waldencast Announces Participation in Upcoming Consumer Conferences
- Waldencast PLC to Report Fourth Quarter 2022 Financial Results on March 15th
- Waldencast PLC Announces Binding Letter of Intent to Acquire 60% of its Southeast Asia Distributor
- Waldencast PLC Announces its Intent to Delay the Filing of its Annual Report and Announces the Consummation of its Previously Announced Acquisition in Southeast Asia
- Waldencast Announces Participation in the TD Cowen 7th Annual Future of the Consumer Conference
- Hind Sebti, Waldencast Co-Founder, recognized as one of the Vogue Business 100 Beauty Disruptors
- Waldencast PLC Announces Private Placement and Expands Leadership Team to Support Growth
- Waldencast plc Announces Fiscal Year 2022 Financial Results
- Hind Sebti, Waldencast Co-Founder & CGO, Selected as Judge for the 2024 Pure Beauty Global Awards
- Waldencast Names Manuel Manfredi as Chief Financial Officer
- Dr. Suzan Obagi Appointed as Chief Medical Director at Obagi Cosmeceuticals, a Subsidiary of Waldencast plc.
- Waldencast Announces Creative Council
- Waldencast Receives Positive Nasdaq Listing Determination
- Waldencast Reports First Half 2023 Results
- Brand
- Investors
- Contact
- Cookie Policy
- Privacy Policy
- Events
